Lorcaserin Hydrochloride Hemihydrate

盐酸绿卡色林

Report date: 2024/11/15 20:00:35
NMEFirst In Class

Base Information

Drug NameLorcaserin Hydrochloride Hemihydrate
Drug Alias Name氯卡色林lorcaserina罗卡西林lorcaserinumlorcaserin +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsMarijuana UseSmoking CessationOpioid-Related Disorders +[16] 
Global Approved IndicationsObesity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/06/27
Country/TerritoryCanadaUnited StatesSouth Korea +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesArena Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNew York State Psychiatric Institute
Inactive CompaniesKanion & Huawe Medicine Co LtdNational Institute On Drug AbuseJohns Hopkins University +[9] 
Active IndicationsMarijuana Use
Inactive IndicationsSmoking CessationOpioid-Related DisordersMarijuana Abuse +[15] 

Other Information

ATC CodeA08AA11
Related LinksWikipediaDrugBankKEGG